Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway

  • Authors:
    • Yi Zhong
    • Cheng Liu
    • Jian Feng
    • Jia‑Fu Li
    • Zhong‑Cai Fan
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Department of Cardiovascular Ultrasound and Cardiac Function, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610000, P.R. China
    Copyright: © Zhong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1856-1870
    |
    Published online on: June 19, 2020
       https://doi.org/10.3892/etm.2020.8915
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to study the molecular mechanism of how curcumin decreases the formation of ox‑LDL induced human monocyte macrophage foam cells, promotes the efflux of cholesterol and reduces the secretion of inflammatory cytokines. In vitro cultured THP‑1 cells were induced to become macrophages using phorbol‑12‑myristate-13‑acetate. The cells were then pre‑treated with curcumin before inducing the foam cell model by addition of oxidized low‑density lipoprotein (ox‑LDL). Western blot assays were used to detect expression levels of toll‑like receptor (TLR)4, nuclear factor κB (NF‑κB), NF‑κB inhibitor α (IκBα), phosphorylated‑IκBα and ATP binding cassette transporter (ABC)A1. Reverse transcription‑quantitative PCR was employed to examine mRNA levels of TLR4, microRNA (miR)33a and ABCA1. ELISAs were used to detect inflammatory factors, including tumor necrosis factor (TNF)‑α, monocyte chemotactic protein (MCP)‑1 and interleukin (IL)‑6. ox‑LDL successfully induced the foam cell model, promoted phosphorylation of IκBα, promoted nuclear translocation of NF‑κB, promoted the expression of TLR4 and miR33a, and promoted the secretion of TNF‑α, MCP‑1 and Il‑6. Additionally, ox‑LDL reduced the expression of ABCA1 and cholesterol efflux. However, pretreatment with curcumin increased the expression of ABCA1 and cholesterol efflux and suppressed secretion of TNF‑α, MCP‑1 and Il‑6. TLR4 antibodies, the NF‑κB blocker, PDTC, and the miR33a inhibitor also reduced the abnormal transformations induced by ox‑LDL. Curcumin promoted cholesterol efflux by suppressing the TLR4/NF‑κB/miR33a signaling pathway, and reduced the formation of foam cells and the secretion of inflammatory factors.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Figure 10

Figure 11

Figure 12

Figure 13

Figure 14

Figure 15

Figure 16

Figure 17

View References

1 

Lancellotti P, Ancion A and Piérard L: Cardiac rehabilitation, state of the art 2017. Rev Med Liege. 72:481–487. 2017.PubMed/NCBI(In French).

2 

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, et al: American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 117(e25-e146)2008.PubMed/NCBI View Article : Google Scholar

3 

Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al: American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 125:188–197. 2012. View Article : Google Scholar

4 

Casas R, Castro-Barquero S, Estruch R and Sacanella E: Nutrition and Cardiovascular Health. Int J Mol Sci. 19(19)2018.PubMed/NCBI View Article : Google Scholar

5 

Veitenhansl M, Stegner K, Hierl FX, Dieterle C, Feldmeier H, et al: 40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5-9 September 2004. Diabetologia. 47 (Suppl 1)(A1-A464)2004.PubMed/NCBI View Article : Google Scholar

6 

Wang Z and Nakayama T: Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010(535918)2010.PubMed/NCBI View Article : Google Scholar

7 

Levi M, van der Poll T and Schultz M: Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost. 38:506–514. 2012.PubMed/NCBI View Article : Google Scholar

8 

Nelken NA, Coughlin SR, Gordon D and Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 88:1121–1127. 1991.PubMed/NCBI View Article : Google Scholar

9 

Boyle JJ, Weissberg PL and Bennett MR: Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol. 23:1553–1558. 2003.PubMed/NCBI View Article : Google Scholar

10 

Jafarzadeh A, Nemati M and Jafarzadeh S: The important role played by chemokines influence the clinical outcome of Helicobacter pylori infection. Life Sci. 231(116688)2019.PubMed/NCBI View Article : Google Scholar

11 

Rull A, Beltrán-Debón R, Aragonès G, Rodríguez-Sanabria F, Alonso-Villaverde C, Camps J and Joven J: Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: Effect of a high-fat, high-cholesterol diet. Cytokine. 50:121–128. 2010.PubMed/NCBI View Article : Google Scholar

12 

Chen S, Sorrentino R, Shimada K, Bulut Y, Doherty TM, Crother TR and Arditi M: Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J Immunol. 181:7186–7193. 2008.PubMed/NCBI View Article : Google Scholar

13 

Zhou Z, Wu Y, Chen L, Liu L, Chen H, Li Z and Chen C: Heat shock protein 10 of Chlamydophila pneumoniae induces proinflammatory cytokines through Toll-like receptor (TLR) 2 and TLR4 in human monocytes THP-1. In Vitro Cell Dev Biol Anim. 47:541–549. 2011.PubMed/NCBI View Article : Google Scholar

14 

Paolillo R, Iovene MR, Romano Carratelli C and Rizzo A: Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae. Int J Immunopathol Pharmacol. 25:377–386. 2012.PubMed/NCBI View Article : Google Scholar

15 

Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843–854. 1993.PubMed/NCBI View Article : Google Scholar

16 

Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar

17 

Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, et al: miR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons. Clin Sci (Lond). 133:583–595. 2019.PubMed/NCBI View Article : Google Scholar

18 

Lin K, Chen H, Chen X, Qian J, Huang S and Huang W: Efficacy of Curcumin on Aortic Atherosclerosis: A Systematic Review and Meta-Analysis in Mouse Studies and Insights into Possible Mechanisms. Oxid Med Cell Longev. 2020(1520747)2020.PubMed/NCBI View Article : Google Scholar

19 

Mohammadian Haftcheshmeh S, Karimzadeh MR, Azhdari S, Vahedi P, Abdollahi E and Momtazi-Borojeni AA: Modulatory effects of curcumin on the atherogenic activities of inflammatory monocytes: Evidence from in vitro and animal models of human atherosclerosis. Biofactors. Dec 24. 2019.PubMed/NCBI View Article : Google Scholar : (Epub ahead of print). View Article : Google Scholar

20 

Dong SZ, Zhao SP, Wu ZH, Yang J, Xie XZ, Yu BL and Nie S: Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway. Mol Cell Biochem. 358:281–285. 2011.PubMed/NCBI View Article : Google Scholar

21 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

22 

Fogelman AM, Shechter I, Seager J, Hokom M, Child JS and Edwards PA: Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA. 77:2214–2218. 1980.PubMed/NCBI View Article : Google Scholar

23 

Weber C and Noels H: Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med. 17:1410–1422. 2011.PubMed/NCBI View Article : Google Scholar

24 

Chiang YM, Lo CP, Chen YP, Wang SY, Yang NS, Kuo YH and Shyur LF: Ethyl caffeate suppresses NF-kappaB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin. Br J Pharmacol. 146:352–363. 2005.PubMed/NCBI View Article : Google Scholar

25 

Coban D, Milenkovic D, Chanet A, Khallou-Laschet J, Sabbe L, Palagani A, Vanden Berghe W, Mazur A and Morand C: Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res. 56:1270–1281. 2012.PubMed/NCBI View Article : Google Scholar

26 

Zhao GJ, Tang SL, Lv YC, Ouyang XP, He PP, Yao F, Chen WJ, Lu Q, Tang YY, Zhang M, et al: Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression. PLoS One. 8(e74782)2013.PubMed/NCBI View Article : Google Scholar

27 

Janeesh PA, Sasikala V, Dhanya CR and Abraham A: Robinin modulates TLR/NF-κB signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells. Int Immunopharmacol. 18:191–197. 2014.PubMed/NCBI View Article : Google Scholar

28 

Sikora E, Scapagnini G and Barbagallo M: Curcumin, inflammation, ageing and age-related diseases. Immun Ageing. 7(1)2010.PubMed/NCBI View Article : Google Scholar

29 

Olszanecki R, Jawień J, Gajda M, Mateuszuk L, Gebska A, Korabiowska M, Chłopicki S and Korbut R: Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol. 56:627–635. 2005.PubMed/NCBI

30 

Zhong Y, Liu T and Guo Z: Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells. Inflamm Res. 61:61–67. 2012.PubMed/NCBI View Article : Google Scholar

31 

Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 272:20963–20966. 1997. View Article : Google Scholar

32 

Zhao GJ, Yin K, Fu YC and Tang CK: The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol Med. 18:149–158. 2012.PubMed/NCBI View Article : Google Scholar

33 

Lee J, Park Y and Koo SI: ATP-binding cassette transporter A1 and HDL metabolism: Effects of fatty acids. J Nutr Biochem. 23:1–7. 2012.PubMed/NCBI View Article : Google Scholar

34 

Yin K, Liao DF and Tang CK: ATP-binding membrane cassette transporter A1 (ABCA1): A possible link between inflammation and reverse cholesterol transport. Mol Med. 16:438–449. 2010.PubMed/NCBI View Article : Google Scholar

35 

Moore KJ, Rayner KJ, Suárez Y and Fernández-Hernando C: The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr. 31:49–63. 2011.PubMed/NCBI View Article : Google Scholar

36 

Moore KJ: microRNAs: Small regulators with a big impact on lipid metabolism. J Lipid Res. 54:1159–1160. 2013.PubMed/NCBI View Article : Google Scholar

37 

Rakcheev AP, Chistiakova IA and Kamennykh PV: [The successful treatment of cutaneous leishmaniasis with an argon laser]. Vestn Dermatol Venerol. 12:53–55. 1989.PubMed/NCBI(In Russian).

38 

Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ and Fernández-Hernando C: miR-33 contributes to the regulation of cholesterol homeostasis. Science. 328:1570–1573. 2010.PubMed/NCBI View Article : Google Scholar

39 

Zhou C, Lei H, Chen Y, Liu Q, Li LC, Moorhead JF, Varghese Z and Ruan XZ: Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation. PLoS One. 8(e75650)2013.PubMed/NCBI View Article : Google Scholar

40 

Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, et al: Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest. 121:2921–2931. 2011.PubMed/NCBI View Article : Google Scholar

41 

Ho PC, Chang KC, Chuang YS and Wei LN: Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J. 25:1758–1766. 2011.PubMed/NCBI View Article : Google Scholar

42 

de Beer MC, Ji A, Jahangiri A, Vaughan AM, de Beer FC, van der Westhuyzen DR and Webb NR: ATP binding cassette G1-dependent cholesterol efflux during inflammation. J Lipid Res. 52:345–353. 2011.PubMed/NCBI View Article : Google Scholar

43 

Shih VF, Tsui R, Caldwell A and Hoffmann A: A single NFκB system for both canonical and non-canonical signaling. Cell Res. 21:86–102. 2011.PubMed/NCBI View Article : Google Scholar

44 

Li Z, Wang S, Zhao W, Sun Z, Yan H and Zhu J: Oxidized low-density lipoprotein upregulates microRNA-146a via JNK and NF-κB signaling. Mol Med Rep. 13:1709–1716. 2016.PubMed/NCBI View Article : Google Scholar

45 

den Dekker WK, Cheng C, Pasterkamp G and Duckers HJ: Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis. 209:314–320. 2010.PubMed/NCBI View Article : Google Scholar

46 

Edfeldt K, Swedenborg J, Hansson GK and Yan ZQ: Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation. 105:1158–1161. 2002.PubMed/NCBI

47 

Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB and Arditi M: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 101:10679–10684. 2004.PubMed/NCBI View Article : Google Scholar

48 

Baker RG, Hayden MS and Ghosh S: NF-κB, inflammation, and metabolic disease. Cell Metab. 13:11–22. 2011.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhong Y, Liu C, Feng J, Li JF and Fan ZC: Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway. Exp Ther Med 20: 1856-1870, 2020.
APA
Zhong, Y., Liu, C., Feng, J., Li, J., & Fan, Z. (2020). Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway. Experimental and Therapeutic Medicine, 20, 1856-1870. https://doi.org/10.3892/etm.2020.8915
MLA
Zhong, Y., Liu, C., Feng, J., Li, J., Fan, Z."Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway". Experimental and Therapeutic Medicine 20.3 (2020): 1856-1870.
Chicago
Zhong, Y., Liu, C., Feng, J., Li, J., Fan, Z."Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway". Experimental and Therapeutic Medicine 20, no. 3 (2020): 1856-1870. https://doi.org/10.3892/etm.2020.8915
Copy and paste a formatted citation
x
Spandidos Publications style
Zhong Y, Liu C, Feng J, Li JF and Fan ZC: Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway. Exp Ther Med 20: 1856-1870, 2020.
APA
Zhong, Y., Liu, C., Feng, J., Li, J., & Fan, Z. (2020). Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway. Experimental and Therapeutic Medicine, 20, 1856-1870. https://doi.org/10.3892/etm.2020.8915
MLA
Zhong, Y., Liu, C., Feng, J., Li, J., Fan, Z."Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway". Experimental and Therapeutic Medicine 20.3 (2020): 1856-1870.
Chicago
Zhong, Y., Liu, C., Feng, J., Li, J., Fan, Z."Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway". Experimental and Therapeutic Medicine 20, no. 3 (2020): 1856-1870. https://doi.org/10.3892/etm.2020.8915
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team